Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Safety in HIV+
NCT01093651Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in human immunodeficiency virus infection (HIV), sponsored by Washington University School of Medicine. Started Jun 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01093651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093651.